Session Details

S063 Advocacy in Dermatology with the Experts: Intersections to Safeguard the Specialty

Mon, Mar 10, 1:00 PM - 4:00 PM
W414C
3 CME Available Symposium NEW
View Map

DESCRIPTION

Open admission to eligible categories, no tuition or ticket

This session will provide an overview of the intersections of advocacy and dermatology from national experts. Diverse content will highlight applications of science, legislation, administrative and judicial policy, and other sociopolitical events to regulation and innovation within the specialty. Speakers will emphasize opportunities to engage with advocacy across the professional continuum. Topics include augmented intelligence, reimbursement and scope of practice, preservation of the patient-physician relationship, climate change, regulatory authorities, DEI and LGBTQ issues, and organized medicine. Speakers will offer engagement tips for advocacy across the professional continuum and how to augment dermatology's voice in local, state, national, and international societies.

LEARNING OBJECTIVES

1.

Describe the role of advocacy in the practice of dermatology, patient care, mitigation of intersectional health disparities and inequity, and the broader advancement of the specialty. List examples of the ways in which advocacy at multiple levels has moved the specialty forward and is poised to do so in the future.

2.

Identify opportunities for engagement with advocacy across the training, professional, and practice continuum.

3.

Discuss novel areas of advocacy focus within dermatology and outline potential ways to spearhead advocacy efforts both at the individual and institutional grassroots levels and through local, regional, national, and international organized medicine.

SCHEDULE

5:00 PM

Symposium Introduction

Klint Peebles, MD, FAAD

5:05 PM

Dermatology in the Broader House of Medicine

Jack S. Resneck Jr., MD, FAAD

5:25 PM

Climate Advocacy in Dermatology: Protecting Skin Health and Equity in a Warming World

Eva R. Parker, MD, FAAD

5:45 PM

Amplifying Impact with Augmented Intelligence

Ivy Lee, MD, FAAD

6:05 PM

Scope of Practice

Aliya Courtney Hines, MD, PhD, FAAD

6:25 PM

Q&A #1

6:40 PM

Healthcare Finance, Medicare, & Payment Reform and DataDerm: A Different Spin on Advocacy

Marta Jane Van Beek, MD, MPH, FAAD

7:00 PM

Rural Access to Dermatology: Challenges, Advocacy and Initiatives

Mary E. Logue, MD, FAAD

7:20 PM

Preserving the Patient-Physician Relationship: Lessons Learned from Gender-Affirming Care & iPLEDGE Reform

Klint Peebles, MD, FAAD

7:40 PM

Q&A #2

SPEAKERS

Aliya Courtney Hines, MD, PhD, FAAD

Aliya Courtney Hines, MD, PhD, FAAD

Ivy Lee, MD, FAAD

Ivy Lee, MD, FAAD

Mary E. Logue, MD, FAAD

Mary E. Logue, MD, FAAD

Eva R. Parker, MD, FAAD

Eva R. Parker, MD, FAAD

Klint Peebles, MD, FAAD

Klint Peebles, MD, FAAD

Jack S. Resneck Jr., MD, FAAD

Jack S. Resneck Jr., MD, FAAD

Marta Jane Van Beek, MD, MPH, FAAD

Marta Jane Van Beek, MD, MPH, FAAD

SPEAKER DISCLOSURES

Aliya Courtney Hines, MD, PhD, FAAD

Functional Fluidics – Founder(Stock);

Ivy Lee, MD, FAAD

DIrect Dermatology – Stockholder(Stock Options);

Mary E. Logue, MD, FAAD

Eli Lilly and Company – Consultant (1099 relationship)(Fees);

Eva R. Parker, MD, FAAD

L'Oreal – Advisory Board(Honoraria), Speaker(Honoraria); Magellan Health – Consultant (1099 relationship)(Honoraria); Trend Sourcing – Consultant (1099 relationship)(Honoraria);

Klint Peebles, MD, FAAD

Kaiser Permanente – Employee(Salary);

Jack S. Resneck Jr., MD, FAAD

No financial relationships exist with ineligible companies.

Marta Jane Van Beek, MD, MPH, FAAD

No financial relationships exist with ineligible companies.